Pharmacokinetics and Efficacy of Multiple Dosing of Lipovirtide for Injection in HIV-infected Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 10, 2022

Primary Completion Date

June 7, 2023

Study Completion Date

September 7, 2023

Conditions

HIV Infections

Interventions

DRUG

Lipovirtide for injection

Multiple dosing of Lipovirtide

Trial Locations (1)

Beijing You'an Hospital, Beijing Medical University, Beijing

All Listed Sponsors

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

lead

Shanxi Kangbao Biological Product Co., Ltd.

INDUSTRY